|
pubmed:abstractText |
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Here, we report a new and effective strategy for inhibiting HCV replication using an inhibitor of heat-shock protein 90, 17-AAG (17-allylamino-17demethoxygeldanamycin), and a proteasome inhibitor, MG132.
|
|
pubmed:affiliation |
Department of Life and Environmental Sciences, Chiba Institute of Technology, Tsudanuma, Narashino, Chiba, Japan.
|
